A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 94, doi. 10.1111/vox.13512
- By:
- Publication type:
- Article
Works matching IS 00429007 AND DT 2024 AND VI 119 AND IP 2
Results: 13
1
2
Safety and protection of plasma donors: A scoping review and evidence gap map.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 110, doi. 10.1111/vox.13544
- By:
- Publication type:
- Article
3
Europe needs 2 million extra donors of blood and plasma: How to find them?
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 121, doi. 10.1111/vox.13540
- By:
- Publication type:
- Article
4
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 102, doi. 10.1111/vox.13516
- By:
- Publication type:
- Article
5
Advancing resilience and sustainability in plasma collections and plasma‐derived medicinal product accessibility.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 93, doi. 10.1111/vox.13597
- By:
- Publication type:
- Article
6
Diary of Events.
- Published in:
- 2024
- Publication type:
- Proceeding
7
The availability of plasma donors and plasma: A sociologist's perspective.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 131, doi. 10.1111/vox.13588
- By:
- Publication type:
- Article
8
Using competition for plasma donor recruitment and retention: An Australian university case study.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 155, doi. 10.1111/vox.13582
- By:
- Publication type:
- Article
9
Risk prediction of iron deficiency for plasmapheresis donors in China: Development and validation of a prediction model.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 144, doi. 10.1111/vox.13572
- By:
- Publication type:
- Article
10
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 134, doi. 10.1111/vox.13569
- By:
- Publication type:
- Article
11
Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 166, doi. 10.1111/vox.13555
- By:
- Publication type:
- Article
12
Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 128, doi. 10.1111/vox.13566
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 2, p. 89, doi. 10.1111/vox.13450
- Publication type:
- Article